Literature DB >> 31727850

GSTM1 Deletion Exaggerates Kidney Injury in Experimental Mouse Models and Confers the Protective Effect of Cruciferous Vegetables in Mice and Humans.

Joseph C Gigliotti1, Adrienne Tin2,3, Shirin Pourafshar1, Sylvia Cechova1, Yves T Wang4, Sun-Sang J Sung1, Gabor Bodonyi-Kovacs1, Janet V Cross5, Guang Yang6, Nhu Nguyen7, Fang Chan1, Casey Rebholz2,3, Bing Yu8, Megan L Grove9, Morgan E Grams3,10, Anna Köttgen2,11, Robert Scharpf12,13, Phillip Ruiz14, Eric Boerwinkle9, Josef Coresh2,3, Thu H Le15,12.   

Abstract

BACKGROUND: GSTM1 encodes glutathione S-transferase μ-1 (GSTM1), which belongs to a superfamily of phase 2 antioxidant enzymes. The highly prevalent GSTM1 deletion variant is associated with kidney disease progression in human cohorts: the African American Study of Kidney Disease and Hypertension and the Atherosclerosis Risk in Communities (ARIC) Study.
METHODS: We generated a Gstm1 knockout mouse line to study its role in a CKD model (involving subtotal nephrectomy) and a hypertension model (induced by angiotensin II). We examined the effect of intake of cruciferous vegetables and GSTM1 genotypes on kidney disease in mice as well as in human ARIC study participants. We also examined the importance of superoxide in the mediating pathways and of hematopoietic GSTM1 on renal inflammation.
RESULTS: Gstm1 knockout mice displayed increased oxidative stress, kidney injury, and inflammation in both models. The central mechanism for kidney injury is likely mediated by oxidative stress, because treatment with Tempol, an superoxide dismutase mimetic, rescued kidney injury in knockout mice without lowering BP. Bone marrow crosstransplantation revealed that Gstm1 deletion in the parenchyma, and not in bone marrow-derived cells, drives renal inflammation. Furthermore, supplementation with cruciferous broccoli powder rich in the precursor to antioxidant-activating sulforaphane significantly ameliorated kidney injury in Gstm1 knockout, but not wild-type mice. Similarly, among humans (ARIC study participants), high consumption of cruciferous vegetables was associated with fewer kidney failure events compared with low consumption, but this association was observed primarily in participants homozygous for the GSTM1 deletion variant.
CONCLUSIONS: Our data support a role for the GSTM1 enzyme in the modulation of oxidative stress, inflammation, and protective metabolites in CKD.
Copyright © 2020 by the American Society of Nephrology.

Entities:  

Keywords:  chronic kidney disease; genetic renal disease; glutathione S-transferase; inflammation; kidney disease progression; oxidative stress

Mesh:

Substances:

Year:  2019        PMID: 31727850      PMCID: PMC6935006          DOI: 10.1681/ASN.2019050449

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  55 in total

1.  Nomenclature for mammalian soluble glutathione transferases.

Authors:  Bengt Mannervik; Philip G Board; John D Hayes; Irving Listowsky; William R Pearson
Journal:  Methods Enzymol       Date:  2005       Impact factor: 1.600

2.  AlphaV-integrins mediate the mechanoprotective action of osteopontin in podocytes.

Authors:  Sandra Schordan; Eric Schordan; Karlhans Endlich; Nicole Endlich
Journal:  Am J Physiol Renal Physiol       Date:  2010-11-03

3.  Characterization of the human class Mu glutathione S-transferase gene cluster and the GSTM1 deletion.

Authors:  S Xu; Y Wang; B Roe; W R Pearson
Journal:  J Biol Chem       Date:  1998-02-06       Impact factor: 5.157

Review 4.  Glutathione S-transferase polymorphisms and colorectal cancer: a HuGE review.

Authors:  S C Cotton; L Sharp; J Little; N Brockton
Journal:  Am J Epidemiol       Date:  2000-01-01       Impact factor: 4.897

5.  Isothiocyanates, glutathione S-transferase M1 and T1 polymorphisms, and lung-cancer risk: a prospective study of men in Shanghai, China.

Authors:  S J London; J M Yuan; F L Chung; Y T Gao; G A Coetzee; R K Ross; M C Yu
Journal:  Lancet       Date:  2000-08-26       Impact factor: 79.321

6.  GSTM1 and NAT2 polymorphisms in operable and non-operable lung cancer patients.

Authors:  S M Hou; D Ryberg; S Fält; A Deverill; T Tefre; A L Børresen; A Haugen; B Lambert
Journal:  Carcinogenesis       Date:  2000-01       Impact factor: 4.944

7.  Association analysis of GSTT1, GSTM1 genotype polymorphisms and serum total GST activity with ischemic stroke risk.

Authors:  Aysun Türkanoğlu; Birsen Can Demirdöğen; Seref Demirkaya; Semai Bek; Orhan Adali
Journal:  Neurol Sci       Date:  2010-06-02       Impact factor: 3.307

8.  The Loss of GSTM1 Associates with Kidney Failure and Heart Failure.

Authors:  Adrienne Tin; Robert Scharpf; Michelle M Estrella; Bing Yu; Megan L Grove; Patricia P Chang; Kunihiro Matsushita; Anna Köttgen; Dan E Arking; Eric Boerwinkle; Thu H Le; Josef Coresh; Morgan E Grams
Journal:  J Am Soc Nephrol       Date:  2017-07-18       Impact factor: 10.121

Review 9.  Novel concepts of broccoli sulforaphanes and disease: induction of phase II antioxidant and detoxification enzymes by enhanced-glucoraphanin broccoli.

Authors:  Don James; Sridevi Devaraj; Prasad Bellur; Shantala Lakkanna; John Vicini; Sekhar Boddupalli
Journal:  Nutr Rev       Date:  2012-10-12       Impact factor: 7.110

10.  Podocyte GTPases regulate kidney filter dynamics.

Authors:  Andreas D Kistler; Mehmet M Altintas; Jochen Reiser
Journal:  Kidney Int       Date:  2012-06       Impact factor: 10.612

View more
  9 in total

Review 1.  Food as medicine: targeting the uraemic phenotype in chronic kidney disease.

Authors:  Denise Mafra; Natalia A Borges; Bengt Lindholm; Paul G Shiels; Pieter Evenepoel; Peter Stenvinkel
Journal:  Nat Rev Nephrol       Date:  2020-09-22       Impact factor: 28.314

Review 2.  GSTM1 Gene, Diet, and Kidney Disease: Implication for Precision Medicine?: Recent Advances in Hypertension.

Authors:  Thu H Le
Journal:  Hypertension       Date:  2021-08-30       Impact factor: 9.897

3.  Association of GSTM1 Deletion With Progression of CKD in Children: Findings From the Chronic Kidney Disease in Children (CKiD) Study.

Authors:  Rebecca V Levy; Kimberly J Reidy; Thu H Le; Victor David; Cheryl Winkler; Yunwen Xu; Bradley Warady; Susan Furth; Frederick Kaskel; Michal L Melamed
Journal:  Am J Kidney Dis       Date:  2021-12-04       Impact factor: 11.072

Review 4.  Eat Your Broccoli: Oxidative Stress, NRF2, and Sulforaphane in Chronic Kidney Disease.

Authors:  Scott E Liebman; Thu H Le
Journal:  Nutrients       Date:  2021-01-18       Impact factor: 5.717

5.  GSTM1 Modulates Expression of Endothelial Adhesion Molecules in Uremic Milieu.

Authors:  Djurdja Jerotic; Sonja Suvakov; Marija Matic; Abdelrahim Alqudah; David J Grieve; Marija Pljesa-Ercegovac; Ana Savic-Radojevic; Tatjana Damjanovic; Nada Dimkovic; Lana McClements; Tatjana Simic
Journal:  Oxid Med Cell Longev       Date:  2021-01-25       Impact factor: 6.543

6.  Comprehensive analysis of the long non-coding RNA expression profile and functional roles in a contrast-induced acute kidney injury rat model.

Authors:  Weiwei Bao; Zhigang Xiao; Zhiqing Wang; Donglin Liu; Ping Tan; Mingfang Huang
Journal:  Exp Ther Med       Date:  2021-05-09       Impact factor: 2.447

7.  Tibetan Medicine Shi-Wei-Gan-Ning-San Alleviates Carbon Tetrachloride-Induced Chronic Liver Injury by Inhibiting TGF-β1 in Wistar Rats.

Authors:  Ziming Jia; Yanhua Zheng; Shaohua Fu; Jingjing Qu; Jie Tian; Wen Qu; Zhinan Mei
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-16       Impact factor: 2.650

8.  Glutathione-S-Transferases as Potential Targets for Modulation of Nitric Oxide-Mediated Vasodilation.

Authors:  Tiffany M Russell; Des R Richardson
Journal:  Biomolecules       Date:  2022-09-13

Review 9.  Pre-Clinical Neuroprotective Evidences and Plausible Mechanisms of Sulforaphane in Alzheimer's Disease.

Authors:  Jiyoung Kim
Journal:  Int J Mol Sci       Date:  2021-03-13       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.